Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry-Reference-Cited by-同舟云学术

Minimal residual disease detection in multiple myeloma: comparison between BML single-tube 10-color multiparameter flow cytometry and EuroFlow multiparameter flow cytometry

Published:2021-08-25 Issue:12 Volume:100 Page:2989-2995
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Sato Kota^ORCID,Okazuka Kiyoshi,Ishida Tadao,Sakamoto Jun,Kaneko Shigeto,Nashimoto Junichiro,Uto Yui,Ogura Mizuki,Yoshiki Yumiko,Abe Yu,Maeda Aki,Hamazaki Hiroyuki,Tsukada Nobuhiro,Hiragohri Yuji,Suzuki Kenshi

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00277-021-04634-5.pdf

Reference19 articles.

1. Landgren O, Iskander K (2017) Modern multiple myeloma therapy: deep, sustained treatment response and good clinical outcomes. J Intern Med 281:365–382. https://doi.org/10.1111/joim.12590

2. Ravi P, Kumar SK, Cerhan JR, Maurer MJ, Dingli D, Ansell SM, Rajkumar SV (2018) Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies. Blood Cancer J 8:26. https://doi.org/10.1038/s41408-018-0065-8

3. Ozaki S, Handa H, Saitoh T, Murakami H, Itagaki M, Asaoku H, Suzuki K, Isoda A, Matsumoto M, Sawamura M, Konishi J, Sunami K, Takezako N, Hagiwara S, Kuroda Y, Chou T, Nagura E, Shimizu K (2015) Trends of survival in patients with multiple myeloma in Japan: a multicenter retrospective collaborative study of the Japanese society of myeloma. Blood Cancer J 5:e349. https://doi.org/10.1038/bcj.2015.79

4. Gagelmann N, Riecken K, Wolschke C, Berger C, Ayuk FA, Fehse B, Kröger N (2020) Development of CAR-T cell therapies for multiple myeloma. Leukemia 34:2317–2332. https://doi.org/10.1038/s41375-020-0930-x

5. Topp MS, Duell J, Zugmaier G, Attal M, Moreau P, Langer C, Krönke J, Facon T, Salnikov AV, Lesley R, Beutner K, Kalabus J, Rasmussen E, Riemann K, Minella AC, Munzert G, Einsele H (2020) Anti-B-cell maturation antigen BiTE molecule AMG 420 induces responses in multiple myeloma. J Clin Oncol 38:775–783. https://doi.org/10.1200/JCO.19.02657

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Voyage of Measurable Residual Disease Assessment in Multiple Myeloma Using Multiparametric Flow Cytometry;Indian Journal of Medical and Paediatric Oncology;2023-04-24

2. “Friends and foes” of multiple myeloma measurable/minimal residual disease evaluation by next generation flow;Frontiers in Oncology;2022-11-28

3. Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma;Journal of Clinical Medicine;2022-03-25